Switch to:
Array BioPharma Inc (NAS:ARRY)
EV/EBITDA
12.29 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Array BioPharma Inc's enterprise value is $364.53 Mil. Array BioPharma Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2015 was $29.67 Mil. Therefore, Array BioPharma Inc's EV/EBITDA ratio for today is 12.29.

ARRY' s EV/EBITDA Range Over the Past 10 Years
Min: -76.5   Max: 165.9
Current: 12.29

-76.5
165.9

During the past 13 years, the highest EV/EBITDA Ratio of Array BioPharma Inc was 165.90. The lowest was -76.50. And the median was -7.10.

ARRY's EV/EBITDA is ranked higher than
61% of the 474 Companies
in the Global Biotechnology industry.

( Industry Median: 18.13 vs. ARRY: 12.29 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Array BioPharma Inc's stock price is $2.91. Array BioPharma Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2015 was $0.07. Therefore, Array BioPharma Inc's P/E Ratio for today is 41.57.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Array BioPharma Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=364.534/29.668
=12.29

Array BioPharma Inc's current Enterprise Value is $364.53 Mil.
Array BioPharma Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2015 was -5.137 (Dec. 2014 ) + 61.855 (Mar. 2015 ) + -9.192 (Jun. 2015 ) + -17.858 (Sep. 2015 ) = $29.67 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Array BioPharma Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=2.91/0.07
=41.57

Array BioPharma Inc's share price for today is $2.91.
Array BioPharma Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2015 was -0.06 (Dec. 2014 ) + 0.37 (Mar. 2015 ) + -0.09 (Jun. 2015 ) + -0.15 (Sep. 2015 ) = $0.07.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15
ev2ebitda -8.57-7.71-2.12-1.74-2.95-5.58-48.01-11.25-8.3340.89

Array BioPharma Inc Quarterly Data

Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
ev2ebitda -14.39-10.75-9.74-8.33-5.60-8.23124.1940.8920.170.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK